Catalyst Pharmaceuticals Stock Price. Everything You Need To Know About The Catalyst Pharmaceuticals Stock!
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company is headquartered in Coral Gables, Florida and currently employs 82 full-time employees. The company went IPO on 2006-11-08. The firm is focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With the patient focus, the Company is engaged in developing a robust pipeline of cutting-edge, medicines for rare diseases. The firm’s New Drug Application for FIRDAPSE (amifampridine) tablets 10 milligrams (mg) for the treatment of adults with Lambert-Eaton myasthenic syndrome (LEMS). The firm’s FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. The firm also has FYCOMPA (perampanel) CIII, a prescription medicine approved in people with epilepsy aged four and older alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures and with other medicines to treat primary generalized tonic-clonic seizures for people with epilepsy aged 12 and older.
Catalyst Pharmaceuticals Stock Price. Everything You Need To Know About The Catalyst Pharmaceuticals Stock! performance
- Employees 82
- Company HQ Coral Gables
- Website https://catalystpharma.com/
- CPRX Asset Type Common Stock
- CPRX Market Capitalization 1.7B
- Earnings Per Share 0.63
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0.346
Are you an investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Catalyst Pharmaceuticals! We understand that making informed investment decisions is crucial, which is why we provide valuable insights and recommendations to retail investors in these countries. Catalyst Pharmaceuticals is an excellent option for investors seeking to invest in real US stocks and Pre-IPO companies. With our platform, you can easily access resources and educational materials to expand your investment knowledge. So, why wait? Take advantage of the opportunities available and learn how you can invest in Catalyst Pharmaceuticals today!
